Detalhe da pesquisa
1.
Elevated Calprotectin and Abnormal Myeloid Cell Subsets Discriminate Severe from Mild COVID-19.
Cell;
182(6): 1401-1418.e18, 2020 09 17.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32810439
2.
Shared and distinct mechanisms of UBA1 inactivation across different diseases.
EMBO J;
43(10): 1919-1946, 2024 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38360993
3.
Molecular and clinical presentation of UBA1-mutated myelodysplastic syndromes.
Blood;
2024 04 30.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38687605
4.
Serious infections in patients with VEXAS syndrome: data from the French VEXAS registry.
Ann Rheum Dis;
83(3): 372-381, 2024 Feb 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38071510
5.
Prognostic impact of DDX41 germline mutations in intensively treated acute myeloid leukemia patients: an ALFA-FILO study.
Blood;
140(7): 756-768, 2022 08 18.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35443031
6.
Involvement of the JAK-STAT pathway in the molecular landscape of tyrosine kinase fusion-negative hypereosinophilic syndromes: A nationwide CEREO study.
Am J Hematol;
99(6): 1108-1118, 2024 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38563187
7.
The spectrum of glomerular and vascular kidney pathology associated with myeloproliferative neoplasms.
Kidney Int;
104(6): 1206-1218, 2023 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37769965
8.
Hematopoietic differentiation is characterized by a transient peak of entropy at a single-cell level.
BMC Biol;
20(1): 60, 2022 03 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35260165
9.
Azacitidine for patients with Vacuoles, E1 Enzyme, X-linked, Autoinflammatory, Somatic syndrome (VEXAS) and myelodysplastic syndrome: data from the French VEXAS registry.
Br J Haematol;
196(4): 969-974, 2022 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34651299
10.
Myeloproliferative neoplasms and clonal haematopoiesis in patients with giant cell arteritis: a case-control and exploratory study.
Rheumatology (Oxford);
61(2): 775-780, 2022 02 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33836046
11.
APR-246 induces early cell death by ferroptosis in acute myeloid leukemia.
Haematologica;
107(2): 403-416, 2022 02 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33406814
12.
Luspatercept (RAP-536) modulates oxidative stress without affecting mutation burden in myelodysplastic syndromes.
Ann Hematol;
101(12): 2633-2643, 2022 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36195681
13.
EZH1/2 function mostly within canonical PRC2 and exhibit proliferation-dependent redundancy that shapes mutational signatures in cancer.
Proc Natl Acad Sci U S A;
116(13): 6075-6080, 2019 03 26.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30867289
14.
Successful nelarabine and venetoclax treatment of a relapsed/refractory mediastinal myeloid sarcoma with clonal TCR rearrangement.
Anticancer Drugs;
32(10): 1118-1122, 2021 11 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34145177
15.
Mastocytosis onset in a patient with treated hairy cell leukemia: Just a coincidence?
Blood Cells Mol Dis;
81: 102392, 2020 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31794934
16.
Pairing MCL-1 inhibition with venetoclax improves therapeutic efficiency of BH3-mimetics in AML.
Eur J Haematol;
105(5): 588-596, 2020 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32659848
17.
Impact of genotype in relapsed and refractory acute myeloid leukaemia patients treated with clofarabine and cytarabine: a retrospective study.
Br J Haematol;
187(1): 65-72, 2019 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31215036
18.
CD13 expression in B cell malignancies is a hallmark of plasmacytic differentiation.
Br J Haematol;
184(4): 625-633, 2019 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30198568
19.
Mutant UBA1 and Severe Adult-Onset Autoinflammatory Disease.
N Engl J Med;
384(22): 2163, 2021 Jun 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34077651
20.
Trismus as a new feature of VEXAS syndrome.
Rheumatology (Oxford);
2024 Mar 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38450422